PharmaShots | Incisive News in 3 Shots

Subscribe Now

episodic

Amgen Reports Results of Aimovig (erenumab-aooe) in P-lV Study for the Treatment of Episodic and Chronic Migraine

Amgen Reports Results of Aimovig (erenumab-aooe) in P-lV Study for the Treatment of Episodic and Chronic Migraine

November 9, 2021

Eli Lilly Reports Results of Emgality (galcanezumab-gnlm) in P-III CONQUER Study for Chronic and Episodic Migraine

Eli Lilly Reports Results of Emgality (galcanezumab-gnlm) in P-III CONQUER Study for Chronic and Episodic Migraine

August 5, 2019

Eli Lilly's Emgality (galcanezumab-gnlm) Receives FDA's Approval for Episodic Cluster Headache in Adults

Eli Lilly's Emgality (galcanezumab-gnlm) Receives FDA's Approval for Episodic Cluster Headache in Adults

June 5, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us